Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)-Reference-Cited by-同舟云学术

Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)

Published:2012-02-24 Issue:5 Volume:55 Page:1831-1843
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Pidathala Chandrakala¹,Amewu Richard¹,Pacorel Bénédicte¹,Nixon Gemma L.²,Gibbons Peter¹,Hong W. David¹,Leung Suet C.¹,Berry Neil G.¹,Sharma Raman²,Stocks Paul A.²,Srivastava Abhishek²,Shone Alison E.²,Charoensutthivarakul Sitthivut¹,Taylor Lee¹,Berger Olivier¹,Mbekeani Alison²,Hill Alasdair²,Fisher Nicholas E.²,Warman Ashley J.²,Biagini Giancarlo A.²,Ward Stephen A.²,O’Neill Paul M.¹

Affiliation:

1. Department of Chemistry, University of Liverpool, Liverpool, L69 7ZD, U.K.

2. Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm201179h

Reference37 articles.

1. The past, present and future of childhood malaria mortality in Africa

2. Antimalarial drug resistance